Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Five-year mortality in patients with diabetic foot ulcer during 2009–2010 was lower than expectedAmadou, C. ; Carlier, A. ; Amouyal, C. ; Bourron, O. ; Aubert, C. ; Couture, T. ; Fourniols, E. ; Ha Van, G. ; Rouanet, S. ; Hartemann, A.Diabetes & metabolism, 2020-06, Vol.46 (3), p.230-235 [Periódico revisado por pares]France: Elsevier Masson SASTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximabRuyssen-Witrand, A ; Rouanet, S ; Combe, B ; Dougados, M ; Le Loët, X ; Sibilia, J ; Tebib, J ; Mariette, X ; Constantin, AAnnals of the rheumatic diseases, 2012-06, Vol.71 (6), p.875-877 [Periódico revisado por pares]London: BMJ Publishing Group Ltd and European League Against RheumatismTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Effect of oral monthly ibandronate on bone microarchitecture in women with osteopenia—a randomized placebo-controlled trialChapurlat, R. D. ; Laroche, M. ; Thomas, T. ; Rouanet, S. ; Delmas, P. D. ; de Vernejoul, M.-C.Osteoporosis international, 2013, Vol.24 (1), p.311-320 [Periódico revisado por pares]London: Springer-VerlagTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
THU0063 Does biologic treatment modify the relationship of the variables associated with fatigue in patients with rheumatoid arthritis? The peps study of tocilizumab in real lifeGossec, L. ; Rouanet, S. ; Steinberg, G. ; Combe, B.Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.174-174 [Periódico revisado por pares]London: BMJ Publishing Group Ltd and European League Against RheumatismTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Topical Ketoprofen Patch (100 mg) for the Treatment of Ankle Sprain: A Randomized, Double-Blind, Placebo-Controlled StudyMazières, Bernard ; Rouanet, Stéphanie ; Velicy, Joanne ; Scarsi, Claudia ; Reiner, ValentinaThe American journal of sports medicine, 2005-04, Vol.33 (4), p.515-523 [Periódico revisado por pares]Los Angeles, CA: SAGE PublicationsTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
SAT0111 Description of Glucocorticoid Sparing Effect in Rheumatoid Arthritis (RA) Patients Treated by Tocilizumab (TCZ) in Real Life: An Interim Analysis of the Spare-1 StudySaraux, A. ; Rouanet, S. ; Flipo, R.-M. ; Poncet, J.-C. ; Fardellone, P. ; Contré, C. ; Cantagrel, A.Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A618-A618 [Periódico revisado por pares]London: BMJ Publishing Group Ltd and European League Against RheumatismTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
THU0087 One single infusion of rituximab 1g might be sufficient in the long-term management of rheumatoid arthritis patients responding to a first cycle of rituximab (2 × 1g): Results of a 2-year multi-center randomized controlled trialDougados, M. ; Combe, B. ; Le Loët, X. ; Tebib, J. ; Sibilia, J. ; Rouanet, S. ; Jourdan, R. ; Mariette, X.Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.182-182 [Periódico revisado por pares]London: BMJ Publishing Group Ltd and European League Against RheumatismTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
1095 25-OH-VITAMIN D LEVEL IS NOT ASSOCIATED WITH THE OUTCOME OF ANTIVIRAL THERAPY IN NAIVE GENOTYPE 1 HCV INFECTED PATIENTSBronowicki, J.-P ; Bouvier-Alias, M ; Rouanet, S ; Pawlotsky, J.-MJournal of hepatology, 2012-04, Vol.56, p.S431-S431 [Periódico revisado por pares]Elsevier B.VTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
FRI0247 Serum level of interleukin 33, a novel independent predictive biomarker of clinical response to rituximab in rheumatoid arthritis: results from the smart trialSellam, J. ; Rouanet, S. ; Hendel-Chavez, H. ; Marion-Thore, S. ; Miceli-Richard, C. ; Combe, B. ; Sibilia, J. ; Le Loët, X. ; Tebib, J. ; Chiocchia, G. ; Jourdan, R. ; Dougados, M. ; Taoufik, Y. ; Mariette, X.Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A457-A457 [Periódico revisado por pares]London: BMJ Publishing Group Ltd and European League Against RheumatismTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
THU0107 CCL19, a chemokine involved in B-cell trafficking, is related to the decrease of blood memory B-cells and predicts the clinical response to rituximab in rheumatoid arthritis: Results from the smart studySellam, J. ; Rouanet, S. ; Hendel-Chavez, H. ; Abbed, K. ; Combe, B. ; Sibilia, J. ; Le Loët, X. ; Tebib, J. ; Jourdan, R. ; Dougados, M. ; Taoufik, Y. ; Mariette, X.Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.190-190 [Periódico revisado por pares]London: BMJ Publishing Group Ltd and European League Against RheumatismTexto completo disponível |